Evergreen Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.74M Sell
17,332
-141
-0.8% -$56.3K 2.63% 14
2026
Q2
$6.76M Sell
17,473
-1,256
-7% -$466K 3.17% 11
2026
Q1
$5.48M Buy
18,729
+1,065
+6% +$350K 2.83% 14
2025
Q4
$6.19M Buy
17,664
+381
+2% +$129K 3.12% 13
2025
Q3
$5.58M Buy
17,283
+4,336
+33% +$1.35M 2.93% 14
2025
Q2
$5.04M Buy
12,947
+1,533
+13% +$617K 2.82% 14
2025
Q1
$4.96M Buy
11,414
+1,673
+17% +$672K 2.97% 11
2024
Q4
$3.59M Buy
9,741
+4,388
+82% +$1.84M 2.12% 17
2024
Q3
$2.78M Buy
5,353
+1,418
+36% +$758K 1.68% 23
2024
Q2
$2.13M Hold
3,935
– – 1.41% 29
2024
Q1
$2.04M Hold
3,935
– – 1.38% 28
2023
Q4
$1.86M Buy
3,935
+102
+3% +$47.2K 1.36% 28
2023
Q3
$1.67M Buy
3,833
+435
+13% +$197K 1.32% 25
2023
Q2
$1.51M Buy
+3,398
New +$1.57M 1.18% 30

Other funds holding ELV

Evergreen Wealth Management's ELV Position: Q3 2026 in Review

Evergreen Wealth Management reduced its Elevance Health (ELV) stake by 0.81% in Q3 2026, selling an estimated $56.3K and leaving 17,332 shares worth $6.74M. The position accounts for 2.63% of the portfolio, ranked #14.

Evergreen Wealth Management first reported a position in ELV in Q2 2023 and has held it in 14 quarters since. The position peaked at $6.76M in Q2 2026. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Evergreen Wealth Management held 17,332 shares of Elevance Health worth $6.74M as of Q3 2026.
  • Evergreen Wealth Management sold 141 Elevance Health shares in Q3 2026, an estimated $56.3K.
  • Elevance Health made up 2.63% of Evergreen Wealth Management's portfolio in Q3 2026, its #14 holding.
  • Evergreen Wealth Management first reported a position in Elevance Health in Q2 2023 and has held it in 14 quarters since.
  • Evergreen Wealth Management's Elevance Health position peaked at $6.76M in Q2 2026.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Evergreen Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.